PNC Financial Services Group’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05K | Sell |
252
-179
| -42% | -$1.45K | ﹤0.01% | 4401 |
|
|
2025
Q1 | $3.03K | Buy |
431
+192
| +80% | +$1.35K | ﹤0.01% | 4226 |
|
|
2024
Q4 | $1.78K | Hold |
239
| – | – | ﹤0.01% | 4312 |
|
|
2024
Q3 | $1.18K | Hold |
239
| – | – | ﹤0.01% | 4409 |
|
|
2024
Q2 | $1.23K | Hold |
239
| – | – | ﹤0.01% | 4384 |
|
|
2024
Q1 | $1.27K | Hold |
239
| – | – | ﹤0.01% | 4313 |
|
|
2023
Q4 | $1.48K | Hold |
239
| – | – | ﹤0.01% | 4239 |
|
|
2023
Q3 | $1.8K | Hold |
239
| – | – | ﹤0.01% | 4272 |
|
|
2023
Q2 | $2.31K | Hold |
239
| – | – | ﹤0.01% | 4339 |
|
|
2023
Q1 | $902 | Buy |
239
+130
| +119% | +$491 | ﹤0.01% | 4454 |
|
|
2022
Q4 | $706 | Buy |
+109
| New | +$706 | ﹤0.01% | 4463 |
|
|
2019
Q2 | – | Sell |
-98
| Closed | -$1K | – | 4082 |
|
|
2019
Q1 | $1K | Hold |
98
| – | – | ﹤0.01% | 3956 |
|
|
2018
Q4 | $1K | Buy |
+98
| New | +$1K | ﹤0.01% | 3962 |
|
|
2017
Q1 | – | Sell |
-58
| Closed | -$1K | – | 4161 |
|
|
2016
Q4 | $1K | Buy |
+58
| New | +$1K | ﹤0.01% | 3926 |
|
|
2016
Q3 | – | Sell |
-83
| Closed | -$1K | – | 4137 |
|
|
2016
Q2 | $1K | Sell |
83
-135
| -62% | -$1.63K | ﹤0.01% | 4358 |
|
|
2016
Q1 | $2K | Buy |
218
+8
| +4% | +$73 | ﹤0.01% | 4191 |
|
|
2015
Q4 | $2K | Hold |
210
| – | – | ﹤0.01% | 4172 |
|
|
2015
Q3 | $2K | Buy |
210
+7
| +3% | +$67 | ﹤0.01% | 4285 |
|
|
2015
Q2 | $3K | Buy |
203
+92
| +83% | +$1.36K | ﹤0.01% | 4270 |
|
|
2015
Q1 | $2K | Hold |
111
| – | – | ﹤0.01% | 4306 |
|
|
2014
Q4 | $2K | Buy |
111
+1
| +0.9% | +$18 | ﹤0.01% | 3803 |
|
|
2014
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 3836 |
|
|
2014
Q2 | $1K | Hold |
110
| – | – | ﹤0.01% | 3690 |
|
|
2014
Q1 | $1K | Buy |
+110
| New | +$1K | ﹤0.01% | 3688 |
|
|
2013
Q4 | – | Sell |
-970
| Closed | -$12K | – | 3474 |
|
|
2013
Q3 | $12K | Sell |
970
-82
| -8% | -$1.01K | ﹤0.01% | 3180 |
|
|
2013
Q2 | $14K | Buy |
+1,052
| New | +$14K | ﹤0.01% | 2921 |
|